Inflammation-Driven Breast Tumor Cell Plasticity: Stemness/EMT, Therapy Resistance and Dormancy

Inflammatory macrophage derived TNFα downregulates estrogen receptor α via FOXO3a inactivation in human breast cancer cells

(2020) Frida Björk Gunnarsdóttir et al.   EXPERIMENTAL CELL RESEARCH

Chemokines and their Receptors: Multifaceted Roles in Cancer Progression and Potential Value as Cancer Prognostic Markers

(2020) Ha Thi Thu Do et al.   Cancers

Lineage plasticity in cancer: a shared pathway of therapeutic resistance

(2020) Álvaro Quintanal-Villalonga et al.   Nature Reviews Clinical Oncology

Targeting STAT3 in cancer and autoimmune diseases

(2020) Tohid Gharibi et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Epithelial–Mesenchymal Transition Programs and Cancer Stem Cell Phenotypes: Mediators of Breast Cancer Therapy Resistance

(2020) Alex J. Gooding et al.   MOLECULAR CANCER RESEARCH

Interplay of EMT and CSC in Cancer and the Potential Therapeutic Strategies

(2020) Shihori Tanabe et al.   Frontiers in Pharmacology

Beyond Cell Motility: The Expanding Roles of Chemokines and Their Receptors in Malignancy

(2020) Dina Morein et al.   Frontiers in Immunology

Re-education of the Tumor Microenvironment With Targeted Therapies and Immunotherapies

(2020) Shin Foong Ngiow et al.   Frontiers in Immunology

The New Era of Cancer Immunotherapy: Targeting Myeloid-Derived Suppressor Cells to Overcome Immune Evasion

(2020) Paola De Cicco et al.   Frontiers in Immunology

Cellular Plasticity in Breast Cancer Progression and Therapy

(2020) Deguang Kong et al.   Frontiers in Molecular Biosciences

Cell plasticity in cancer: A complex interplay of genetic, epigenetic mechanisms and tumor micro-environment

(2020) Santosh Shenoy   SURGICAL ONCOLOGY-OXFORD

Targeting Myeloid-Derived Suppressor Cells in Cancer Immunotherapy

(2020) Yufei Wang et al.   Cancers

Tumor-Associated Macrophages Induce Endocrine Therapy Resistance in ER+ Breast Cancer Cells

(2019) Andrés M. Castellaro et al.   Cancers

MCT-1/miR-34a/IL-6/IL-6R signaling axis promotes EMT progression, cancer stemness and M2 macrophage polarization in triple-negative breast cancer

(2019) Yueh-Shan Weng et al.   Molecular Cancer

Induction of breast cancer stem cells by M1 macrophages through Lin-28B-let-7-HMGA2 axis

(2019) Liang Guo et al.   CANCER LETTERS

Potential roles and targeted therapy of the CXCLs/CXCR2 axis in cancer and inflammatory diseases

(2019) Yuan Cheng et al.   BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER

T-cell recognition of non-mutated tumor antigens in healthy individuals: connecting endogenous immunity and tumor dormancy

(2019) Constantin N. Baxevanis   CANCER IMMUNOLOGY IMMUNOTHERAPY

Inflammatory Breast Cancer Promotes Development of M2 Tumor-associated Macrophages and Cancer Mesenchymal Cells Through a Complex Cytokine Network

(2019) Amanda Valeta-Magara et al.   CANCER RESEARCH

Targeting Interleukin-6 Signaling in Clinic

(2019) Sujin Kang et al.   IMMUNITY

Targeting Tumor-Associated Macrophages in Cancer

(2019) Paulina Pathria et al.   TRENDS IN IMMUNOLOGY

CCL5 promotes breast cancer recurrence through macrophage recruitment in residual tumors

(2019) Andrea Walens et al.   eLife

Recent Advances targeting CCR5 for Cancer and its Role in Immuno-Oncology

(2019) Xuanmao Jiao et al.   CANCER RESEARCH

Pas de Deux: Control of Anti-tumor Immunity by Cancer-Associated Inflammation

(2019) Shabnam Shalapour et al.   IMMUNITY

Inflammation and Cancer: Triggers, Mechanisms, and Consequences

(2019) Florian R. Greten et al.   IMMUNITY

Preoperative stimulation of resolution and inflammation blockade eradicates micrometastases

(2019) Dipak Panigrahy et al.   JOURNAL OF CLINICAL INVESTIGATION

Tumor-Stroma-Inflammation Networks Promote Pro-metastatic Chemokines and Aggressiveness Characteristics in Triple-Negative Breast Cancer

(2019) Yulia Liubomirski et al.   Frontiers in Immunology

Notch-Mediated Tumor-Stroma-Inflammation Networks Promote Invasive Properties and CXCL8 Expression in Triple-Negative Breast Cancer

(2019) Yulia Liubomirski et al.   Frontiers in Immunology

Stem Cell Plasticity and Dormancy in the Development of Cancer Therapy Resistance

(2019) Maria Laura De Angelis et al.   Frontiers in Oncology

Targeting Immune-Mediated Dormancy: A Promising Treatment of Cancer

(2019) Hao-fan Wang et al.   Frontiers in Oncology

Targeting tumor phenotypic plasticity and metabolic remodeling in adaptive cross-drug tolerance

(2019) Aaron Goldman et al.   Science Signaling

Breast cancer

(2019) Nadia Harbeck et al.   Nature Reviews Disease Primers

CSCs in Breast Cancer—One Size Does Not Fit All: Therapeutic Advances in Targeting Heterogeneous Epithelial and Mesenchymal CSCs

(2019) Andrew Sulaiman et al.   Cancers

The CXCL5/CXCR2 axis is sufficient to promote breast cancer colonization during bone metastasis

(2019) Ricardo Romero-Moreno et al.   Nature Communications

Breast Cancer Stem Cells as Drivers of Tumor Chemoresistance, Dormancy and Relapse: New Challenges and Therapeutic Opportunities

(2019) De Angelis et al.   Cancers

Partners in crime: TNFα-based networks promoting cancer progression

(2019) Adit Ben-Baruch   CANCER IMMUNOLOGY IMMUNOTHERAPY

Tumor‐associated macrophages secrete CC‐chemokine ligand 2 and induce tamoxifen resistance by activating PI3K/Akt/mTOR in breast cancer

(2019) Dongbo Li et al.   CANCER SCIENCE

What Is the Role of Interleukins in Breast Cancer Bone Metastases? A Systematic Review of Preclinical and Clinical Evidence

(2019) Francesca Salamanna et al.   Cancers

CXCR2 promotes breast cancer metastasis and chemoresistance via suppression of AKT1 and activation of COX2

(2018) Han Xu et al.   CANCER LETTERS

Combined blockade of IL-6 and PD-1/PD-L1 signaling abrogates mutual regulation of their immunosuppressive effects in the tumor microenvironment

(2018) Hirotake Tsukamoto et al.   CANCER RESEARCH

JAK/STAT3-Regulated Fatty Acid β-Oxidation Is Critical for Breast Cancer Stem Cell Self-Renewal and Chemoresistance

(2018) Tianyi Wang et al.   Cell Metabolism

The role of IL-1B in breast cancer bone metastasis

(2018) Claudia Tulotta et al.   ENDOCRINE-RELATED CANCER

Stat3/Oct-4/c-Myc signal circuit for regulating stemness-mediated doxorubicin resistance of triple-negative breast cancer cells and inhibitory effects of WP1066

(2018) Cong-Cong Cheng et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

Transmembrane TNF-alpha promotes chemoresistance in breast cancer cells

(2018) Zunyue Zhang et al.   ONCOGENE

The systemic response to surgery triggers the outgrowth of distant immune-controlled tumors in mouse models of dormancy

(2018) Jordan A. Krall et al.   Science Translational Medicine

Interferon-Gamma at the Crossroads of Tumor Immune Surveillance or Evasion

(2018) Flávia Castro et al.   Frontiers in Immunology

Targeting Macrophages in Cancer: From Bench to Bedside

(2018) Ashleigh R. Poh et al.   Frontiers in Oncology

Interleukin-22 promotes triple negative breast cancer cells migration and paclitaxel resistance through JAK-STAT3/MAPKs/AKT signaling pathways

(2018) Shuqian Wang et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Tumor-associated macrophages in breast cancer: Innocent bystander or important player?

(2018) Si-Qi Qiu et al.   CANCER TREATMENT REVIEWS

Reawakening of dormant estrogen-dependent human breast cancer cells by bone marrow stroma secretory senescence

(2018) Samir Tivari et al.   Cell Communication and Signaling

Interleukin-1 Beta—A Friend or Foe in Malignancies?

(2018) Rebekka Bent et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

STAT3 in Breast Cancer Onset and Progression: A Matter of Time and Context

(2018) Ilenia Segatto et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Cancer cell plasticity: Impact on tumor progression and therapy response

(2018) Victoria da Silva-Diz et al.   SEMINARS IN CANCER BIOLOGY

CXCL1 derived from tumor-associated macrophages promotes breast cancer metastasis via activating NF-κB/SOX4 signaling

(2018) Neng Wang et al.   Cell Death & Disease

The role of the interleukin (IL)-6/IL-6 receptor axis in cancer

(2018) Mustafa Yassin Taher et al.   BIOCHEMICAL SOCIETY TRANSACTIONS

Pro-inflammatory cytokines: The link between obesity and osteoarthritis

(2018) Tiantian Wang et al.   CYTOKINE & GROWTH FACTOR REVIEWS

IL-6 inhibitor for the treatment of rheumatoid arthritis: A comprehensive review

(2018) Atsushi Ogata et al.   Modern Rheumatology

Dormant tumour cells, their niches and the influence of immunity

(2018) Erica T. Goddard et al.   NATURE CELL BIOLOGY

Targeting macrophages: therapeutic approaches in cancer

(2018) Luca Cassetta et al.   NATURE REVIEWS DRUG DISCOVERY

Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer

(2018) Peter Schmid et al.   NEW ENGLAND JOURNAL OF MEDICINE

Blocking IL-1β reverses the immunosuppression in mouse breast cancer and synergizes with anti–PD-1 for tumor abrogation

(2018) Irena Kaplanov et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Potential Role of CXCR4 Targeting in the Context of Radiotherapy and Immunotherapy of Cancer

(2018) Franziska Eckert et al.   Frontiers in Immunology

Cellular Phenotype Plasticity in Cancer Dormancy and Metastasis

(2018) Xiao Yang et al.   Frontiers in Oncology

Treg depletion potentiates checkpoint inhibition in claudin-low breast cancer

(2017) Nicholas A. Taylor et al.   JOURNAL OF CLINICAL INVESTIGATION

Implications of the tumor immune microenvironment for staging and therapeutics

(2017) Janis M Taube et al.   MODERN PATHOLOGY

Intra-tumor heterogeneity from a cancer stem cell perspective

(2017) Pramudita R. Prasetyanti et al.   Molecular Cancer

TNFR2 promotes Adriamycin resistance in breast cancer cells by repairing DNA damage

(2017) Fuqian Yang et al.   Molecular Medicine Reports

Cancer stem cells revisited

(2017) Eduard Batlle et al.   NATURE MEDICINE

The immune contexture in cancer prognosis and treatment

(2017) Wolf H. Fridman et al.   Nature Reviews Clinical Oncology

Tumour-associated macrophages as treatment targets in oncology

(2017) Alberto Mantovani et al.   Nature Reviews Clinical Oncology

GROα overexpression drives cell migration and invasion in triple negative breast cancer cells

(2017) Kruttika Bhat et al.   ONCOLOGY REPORTS

An autocrine inflammatory forward-feedback loop after chemotherapy withdrawal facilitates the repopulation of drug-resistant breast cancer cells

(2017) Deyong Jia et al.   Cell Death & Disease

Drugs for Autoimmune Inflammatory Diseases: From Small Molecule Compounds to Anti-TNF Biologics

(2017) Ping Li et al.   Frontiers in Pharmacology

Co-Inflammatory Roles of TGFβ1 in the Presence of TNFα Drive a Pro-inflammatory Fate in Mesenchymal Stem Cells

(2017) Shalom Lerrer et al.   Frontiers in Immunology

Network-pharmacology-based validation of TAMS/CXCL-1 as key mediator of XIAOPI formula preventing breast cancer development and metastasis

(2017) Neng Wang et al.   Scientific Reports

The recurrence pattern following delayed breast reconstruction after mastectomy for breast cancer suggests a systemic effect of surgery on occult dormant micrometastases

(2016) Hanna Dillekås et al.   BREAST CANCER RESEARCH AND TREATMENT

Induction of CXCR2 ligands, stem cell-like phenotype, and metastasis in chemotherapy-resistant breast cancer cells

(2016) Bhawna Sharma et al.   CANCER LETTERS

Myeloid-Derived Suppressor Cells Endow Stem-like Qualities to Breast Cancer Cells through IL6/STAT3 and NO/NOTCH Cross-talk Signaling

(2016) D. Peng et al.   CANCER RESEARCH

Inflammation Triggers Zeb1-Dependent Escape from Tumor Latency

(2016) Jasmine M. De Cock et al.   CANCER RESEARCH

A Breakthrough: Macrophage-Directed Cancer Immunotherapy

(2016) C. D. Mills et al.   CANCER RESEARCH

TNFα-Induced Mucin 4 Expression Elicits Trastuzumab Resistance in HER2-Positive Breast Cancer

(2016) María F. Mercogliano et al.   CLINICAL CANCER RESEARCH

Regulatory T Cells Exhibit Distinct Features in Human Breast Cancer

(2016) George Plitas et al.   IMMUNITY

PI3Kγ is a molecular switch that controls immune suppression

(2016) Megan M. Kaneda et al.   NATURE

Induction of LIFR confers a dormancy phenotype in breast cancer cells disseminated to the bone marrow

(2016) Rachelle W. Johnson et al.   NATURE CELL BIOLOGY

Molecular mechanism of action of anti-tumor necrosis factor antibodies in inflammatory bowel diseases

(2016) Ulrike Billmeier et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Microenvironmental networks promote tumor heterogeneity and enrich for metastatic cancer stem-like cells in Luminal-A breast tumor cells

(2016) Polina Weitzenfeld et al.   Oncotarget

Targeting the CCL2-CCR2 signaling axis in cancer metastasis

(2016) Su Yin Lim et al.   Oncotarget

Activation of IL-8 via PI3K/Akt-dependent pathway is involved in leptin-mediated epithelial-mesenchymal transition in human breast cancer cells

(2015) Lin Wang et al.   CANCER BIOLOGY & THERAPY

Perivascular M2 Macrophages Stimulate Tumor Relapse after Chemotherapy

(2015) R. Hughes et al.   CANCER RESEARCH

Therapeutic Implications of Cellular Heterogeneity and Plasticity in Breast Cancer

(2015) Michael D. Brooks et al.   Cell Stem Cell

Dormancy and growth of metastatic breast cancer cells in a bone-like microenvironment

(2015) Donna M. Sosnoski et al.   CLINICAL & EXPERIMENTAL METASTASIS

Intratumoral Delivery of IL-21 Overcomes Anti-Her2/Neu Resistance through Shifting Tumor-Associated Macrophages from M2 to M1 Phenotype

(2015) Meng Xu et al.   JOURNAL OF IMMUNOLOGY

Inflammatory Factors of the Tumor Microenvironment Induce Plasticity in Nontransformed Breast Epithelial Cells: EMT, Invasion, and Collapse of Normally Organized Breast Textures

(2015) Tal Leibovich-Rivkin et al.   NEOPLASIA

Breast cancer stem cells, EMT and therapeutic targets

(2014) Srishti Kotiyal et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease

(2014) Mark D. Turner et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH

The inflammatory cytokine TNFα cooperates with Ras in elevating metastasis and turns WT-Ras to a tumor-promoting entity in MCF-7 cells

(2014) Tal Leibovich-Rivkin et al.   BMC CANCER

NSAID Use Reduces Breast Cancer Recurrence in Overweight and Obese Women: Role of Prostaglandin-Aromatase Interactions

(2014) L. W. Bowers et al.   CANCER RESEARCH

Macrophage Activation and Polarization: Nomenclature and Experimental Guidelines

(2014) Peter J. Murray et al.   IMMUNITY

Plasticity of Macrophage Function during Tumor Progression: Regulation by Distinct Molecular Mechanisms

(2014) S. K. Biswas et al.   JOURNAL OF IMMUNOLOGY

A breast cancer stem cell niche supported by juxtacrine signalling from monocytes and macrophages

(2014) Haihui Lu et al.   NATURE CELL BIOLOGY

IL-6 secreted by cancer-associated fibroblasts induces tamoxifen resistance in luminal breast cancer

(2014) X Sun et al.   ONCOGENE

Tumor-Associated Macrophages are Correlated with Tamoxifen Resistance in the Postmenopausal Breast Cancer Patients

(2014) Qi-jia Xuan et al.   PATHOLOGY & ONCOLOGY RESEARCH

Eradication of metastatic mouse cancers resistant to immune checkpoint blockade by suppression of myeloid-derived cells

(2014) K. Kim et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Hypoxia-inducible factors are required for chemotherapy resistance of breast cancer stem cells

(2014) Debangshu Samanta et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Mesenchymal Stem Cell-Induced Doxorubicin Resistance in Triple Negative Breast Cancer

(2014) Dar-Ren Chen et al.   Biomed Research International

The depletion of Interleukin-8 causes cell cycle arrest and increases the efficacy of docetaxel in breast cancer cells

(2013) Nan Shao et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

The chemokine system, and its CCR5 and CXCR4 receptors, as potential targets for personalized therapy in cancer

(2013) Polina Weitzenfeld et al.   CANCER LETTERS

Role of the IL-6-JAK1-STAT3-Oct-4 pathway in the conversion of non-stem cancer cells into cancer stem-like cells

(2013) Seog-Young Kim et al.   CELLULAR SIGNALLING

Reduction of Breast Cancer Relapses with Perioperative Non-Steroidal Anti-Inflammatory Drugs: New Findings and a Review

(2013) Michael Retsky et al.   CURRENT MEDICINAL CHEMISTRY

Progression of Luminal Breast Tumors Is Promoted by Ménage à Trois between the Inflammatory Cytokine TNFαand the Hormonal and Growth-Supporting Arms of the Tumor Microenvironment

(2013) Polina Weitzenfeld et al.   MEDIATORS OF INFLAMMATION

Targeting CXCR2 Enhances Chemotherapeutic Response, Inhibits Mammary Tumor Growth, Angiogenesis, and Lung Metastasis

(2013) B. Sharma et al.   MOLECULAR CANCER THERAPEUTICS

Tumour heterogeneity and cancer cell plasticity

(2013) Corbin E. Meacham et al.   NATURE

The epigenetics of epithelial-mesenchymal plasticity in cancer

(2013) Wai Leong Tam et al.   NATURE MEDICINE

Inflammatory chemokines and metastasis—tracing the accessory

(2013) L Borsig et al.   ONCOGENE

Chemokine Expression in Inflamed Adipose Tissue Is Mainly Mediated by NF-κB

(2013) Franck Tourniaire et al.   PLoS One

TWIST1 associates with NF-κB subunit RELA via carboxyl-terminal WR domain to promote cell autonomous invasion through IL8 production

(2012) Shan Li et al.   BMC BIOLOGY

NSAID analgesic ketorolac used perioperatively may suppress early breast cancer relapse: particular relevance to triple negative subgroup

(2012) Michael Retsky et al.   BREAST CANCER RESEARCH AND TREATMENT

Impaired IFN-  Production by Plasmacytoid Dendritic Cells Favors Regulatory T-cell Expansion That May Contribute to Breast Cancer Progression

(2012) V. Sisirak et al.   CANCER RESEARCH

Epithelial-Mesenchymal Transition Induced by TNF-  Requires NF- B-Mediated Transcriptional Upregulation of Twist1

(2012) C.-W. Li et al.   CANCER RESEARCH

A CXCL1 Paracrine Network Links Cancer Chemoresistance and Metastasis

(2012) Swarnali Acharyya et al.   CELL

EMT-activating transcription factors in cancer: beyond EMT and tumor invasiveness

(2012) Ester Sánchez-Tilló et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Targeting CXCR1/2 Significantly Reduces Breast Cancer Stem Cell Activity and Increases the Efficacy of Inhibiting HER2 via HER2-Dependent and -Independent Mechanisms

(2012) J. K. Singh et al.   CLINICAL CANCER RESEARCH

STAT3-RANTES Autocrine Signaling Is Essential for Tamoxifen Resistance in Human Breast Cancer Cells

(2012) E. H. Yi et al.   MOLECULAR CANCER RESEARCH

Activation of an IL6 Inflammatory Loop Mediates Trastuzumab Resistance in HER2+ Breast Cancer by Expanding the Cancer Stem Cell Population

(2012) Hasan Korkaya et al.   MOLECULAR CELL

LIFR is a breast cancer metastasis suppressor upstream of the Hippo-YAP pathway and a prognostic marker

(2012) Dahu Chen et al.   NATURE MEDICINE

Altered Death Receptor Signaling Promotes Epithelial-to-Mesenchymal Transition and Acquired Chemoresistance

(2012) James W. Antoon et al.   Scientific Reports

Inflammatory mediators in breast cancer: Coordinated expression of TNFα & IL-1β with CCL2 & CCL5 and effects on epithelial-to-mesenchymal transition

(2011) Gali Soria et al.   BMC CANCER

TGF /TNF -Mediated Epithelial-Mesenchymal Transition Generates Breast Cancer Stem Cells with a Claudin-Low Phenotype

(2011) M. K. Asiedu et al.   CANCER RESEARCH

IL-8 Signaling Plays a Critical Role in the Epithelial-Mesenchymal Transition of Human Carcinoma Cells

(2011) R. I. Fernando et al.   CANCER RESEARCH

Molecular biology in breast cancer: Intrinsic subtypes and signaling pathways

(2011) Pilar Eroles et al.   CANCER TREATMENT REVIEWS

Macrophages and cathepsin proteases blunt chemotherapeutic response in breast cancer

(2011) T. Shree et al.   GENES & DEVELOPMENT

The JAK2/STAT3 signaling pathway is required for growth of CD44+CD24– stem cell–like breast cancer cells in human tumors

(2011) Lauren L.C. Marotta et al.   JOURNAL OF CLINICAL INVESTIGATION

The chemokine system and cancer

(2011) Frances R Balkwill   JOURNAL OF PATHOLOGY

Inducible formation of breast cancer stem cells and their dynamic equilibrium with non-stem cancer cells via IL6 secretion

(2011) D. Iliopoulos et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Do Intraoperative Analgesics Influence Breast Cancer Recurrence After Mastectomy? A Retrospective Analysis

(2010) Patrice Forget et al.   ANESTHESIA AND ANALGESIA

Framework models of tumor dormancy from patient-derived observations

(2010) Christoph A Klein   CURRENT OPINION IN GENETICS & DEVELOPMENT

TNFalpha up-regulates SLUG via the NF-kappaB/HIF1alpha axis, which imparts breast cancer cells with a stem cell-like phenotype

(2010) Gianluca Storci et al.   JOURNAL OF CELLULAR PHYSIOLOGY

CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts

(2010) Christophe Ginestier et al.   JOURNAL OF CLINICAL INVESTIGATION

Stabilization of Snail by NF-κB Is Required for Inflammation-Induced Cell Migration and Invasion

(2009) Yadi Wu et al.   CANCER CELL

Breast Cancer Cell Lines Contain Functional Cancer Stem Cells with Metastatic Capacity and a Distinct Molecular Signature

(2009) Emmanuelle Charafe-Jauffret et al.   CANCER RESEARCH

Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability

(2009) F. Colotta et al.   CARCINOGENESIS

Interleukin-6 induces an epithelial–mesenchymal transition phenotype in human breast cancer cells

(2009) N J Sullivan et al.   ONCOGENE

Dormancy and surgery-driven escape from dormancy help explain some clinical features of breast cancer 

(2008) M. W. RETSKY et al.   APMIS

Rb Depletion Results in Deregulation of E-Cadherin and Induction of Cellular Phenotypic Changes that Are Characteristic of the Epithelial-to-Mesenchymal Transition

(2008) Y. Arima et al.   CANCER RESEARCH